# Clinical Utility of MyProstateScore 2.0 P2

> **NCT05910697** · NA · TERMINATED · sponsor: **Qure Healthcare, LLC** · enrollment: 142 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **OTHER:** MyProstateScore 2.0 Results

## Key facts

- **NCT ID:** NCT05910697
- **Lead sponsor:** Qure Healthcare, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-03-31
- **Primary completion:** 2023-10-18
- **Final completion:** 2023-10-18
- **Target enrollment:** 142 (ACTUAL)
- **Why stopped:** The decision to stop the study was made by the sponsor, based solely on timeline constraints.
- **Last updated:** 2023-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05910697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05910697, "Clinical Utility of MyProstateScore 2.0 P2". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT05910697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*